Giancarlo Pruneri, Professor of Pathological Anatomy at the University of Milan and Director of the Department of Pathology and Laboratory Medicine of the IRCCS National Cancer Institute of Milan, explains the importance of new generation sequencing methods, such as Comprehensive Genomic Profiling and the cost-benefit ratio of the Molecular Tumor Board established at the National Cancer Institute.
#Pruneri #Molecular #Tumor #Board #sustainable #costs #great #benefits